Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
68,523
Sort by:
Global Clinical Risk Grouping Solutions Market Size study, by Product (Scorecards & Visualization Tools, Dashboard Analytics Solutions, Risk Reporting Solutions), by Deployment (Private Cloud, Public Cloud, Hybrid Cloud), by End-User (Hospitals, Payers, Ambulatory Care Centers, Others) and Regional Forecasts 2019-2026
US$ 3,750.00
Global Clinical Risk Grouping Solutions Market is valued approximately at USD 369.70 million in 2018 and is anticipated to grow with a healthy growth rate of more than 15.5% over the forecast period 2...
February 2020
200 pages
Global Vitamins Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
US$ 3,480.00
... 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Vitamins, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze ...
February 2020
102 pages
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders) pipeline guide also reviews of key players involved in therapeutic development for Uterine Leiomyoma (Uterine Fibroids) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
January 2020
113 pages
Erectile Dysfunction - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Erectile Dysfunction (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Erectile Dysfunction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
150 pages
Male Hypogonadism - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Male Hypogonadism (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Male Hypogonadism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
107 pages
Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Ventilator Associated Pneumonia (VAP) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Ventilator Associated Pneumonia (VAP) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
176 pages
Amyloidosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Amyloidosis (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Amyloidosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
226 pages
Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Onychomycosis (Tinea Unguium) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Onychomycosis (Tinea Unguium) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
83 pages
Rheumatoid Arthritis - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Rheumatoid Arthritis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Rheumatoid Arthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
1156 pages
Smallpox - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Smallpox (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Smallpox and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
81 pages
Acute Respiratory Distress Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Acute Respiratory Distress Syndrome (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Acute Respiratory Distress Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
129 pages
Cholera - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Cholera (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cholera and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
63 pages
Typhoid Fever - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Typhoid Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Typhoid Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
52 pages
Diabetic Macular Edema - Pipeline Review, H1 2020
US$ 2,000.00
... . The Diabetic Macular Edema (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Macular Edema and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
298 pages
Sarcopenia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Sarcopenia (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sarcopenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
91 pages
Anthrax - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Anthrax (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Anthrax and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
110 pages
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Hospital Acquired Pneumonia (HAP) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hospital Acquired Pneumonia (HAP) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
199 pages
Hypoglycemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hypoglycemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hypoglycemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
88 pages
Mumps - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Mumps (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Mumps and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
31 pages
Warts - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Warts (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Warts and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
111 pages
Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2020
US$ 2,000.00
... . The Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Nausea and Vomiting and features dormant and discontinued projects. The guide covers therapeutics under Development ...
January 2020
99 pages
Chemotherapy Induced Neutropenia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Chemotherapy Induced Neutropenia (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Neutropenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
146 pages
Insulin Resistance - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Insulin Resistance (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Insulin Resistance and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
51 pages
Bacterial Vaginosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Bacterial Vaginosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Bacterial Vaginosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
72 pages
Degenerative Disc Disease - Pipeline Review, H1 2020
US$ 2,000.00
... . The Degenerative Disc Disease (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Degenerative Disc Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
68 pages
Diabetic Peripheral Neuropathy - Pipeline Review, H1 2020
US$ 2,000.00
... . The Diabetic Peripheral Neuropathy (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Peripheral Neuropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
86 pages
Plague - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Plague (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Plague and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
70 pages
Botulism - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Botulism (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Botulism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
36 pages
Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Opioid-Induced Constipation (OIC) (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Opioid-Induced Constipation (OIC) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
53 pages
Lyme Disease - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Lyme Disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Lyme Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
59 pages
Streptococcus pyogenes Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Streptococcus pyogenes Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Streptococcus pyogenes Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
35 pages
Community Acquired Pneumonia - Pipeline Review, H1 2020
US$ 2,000.00
... . The Community Acquired Pneumonia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Community Acquired Pneumonia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
151 pages
Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Elephantiasis (Lymphatic Filariasis) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Elephantiasis (Lymphatic Filariasis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
31 pages
Phenylketonuria (PKU) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Phenylketonuria (PKU) (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Phenylketonuria (PKU) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
82 pages
Global Atopic Dermatitis (AD) Market: Analysis By Therapy (Biologic, Oral, Topical, Photo), End User, Pipeline, By Region, By Country (2020 Edition): Market Insight, Competition and Forecast (2019-2024)
US$ 2,200.00
EXECUTIVE SUMMARY Global Atopic Dermatitis Market was valued at USD 9095.16 Million in the year 2018. Rise in pollution levels, growing urbanization, unhealthy lifestyle, increase in number of aller...
January 2020
225 pages
Asia Pacific Oculoplastic Surgery Market (2019-2025)
US$ 1,500.00
The Asia Pacific Oculoplastic Surgery Market would witness market growth of 6.98% CAGR during the forecast period (2019-2025). A forehead lift can benefit people of any age who have formed furrows or...
January 2020
65 pages
Asia Pacific Rhinoplasty Market (2019-2025)
US$ 1,500.00
The Asia Pacific Rhinoplasty Market would witness market growth of 7.9% CAGR during the forecast period (2019-2025). Social media is also expected to play a vital role in raising market demand. The ex...
January 2020
65 pages
Europe Oculoplastic Surgery Market (2019-2025)
US$ 1,500.00
The Europe Oculoplastic Surgery Market would witness market growth of 5.29% CAGR during the forecast period (2019-2025). The field of oculoplastic surgery takes much of the plastic surgery principle a...
January 2020
65 pages
Europe Rhinoplasty Market (2019-2025)
US$ 1,500.00
The Europe Rhinoplasty Market would witness market growth of 6.04% CAGR during the forecast period (2019-2025). Many people have expressed their concerns about the crookedness of their noses, which ma...
January 2020
65 pages
